MARY ANN GRAY Insider Trading Transactions
Get free email notifications about insider trading for MARY ANN GRAY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARY ANN GRAY. MARY ANN GRAY is Director in JUNIPER PHARMACEUTICALS INC ($JNP) and Director in Sarepta Therapeutics, Inc. ($SRPT) and in DYAX CORP ($DYAX) and Director in DYAX CORP ($DYAX) and Director in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX) and in ACADIA PHARMACEUTICALS INC ($ACAD) and Director in SENOMYX INC ($SNMX) and Director in Seneca Biopharma, Inc. ($SNCA) and Director in Galena Biopharma, Inc. ($GALE) and Director in Keros Therapeutics, Inc. ($KROS) and in RAPT Therapeutics, Inc. ($RAPT) and Director in RAPT Therapeutics, Inc. ($RAPT).
Latest Insider Trading Transactions of MARY ANN GRAY
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACAD, DYAX, JNP, KROS, MBVX, SNCA, RAPT, SRPT, SLS, SNMX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 24 2021 | RAPT | RAPT Therapeutics, ... | GRAY MARY ANN | Option Exercise | A | 19.30 | 7,500 | 144,750 | 7,500 | ||
Apr 26 2021 | SNCA | Seneca Biopharma, ... | GRAY MARY ANN | Director | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
Apr 02 2021 | RAPT | RAPT Therapeutics, ... | GRAY MARY ANN | Option Exercise | A | 22.20 | 3,822 | 84,848 | 3,822 | ||
Mar 05 2021 | SRPT | Sarepta Therapeuti ... | GRAY MARY ANN | Director | Option Exercise | A | 87.11 | 5,518 | 480,673 | 5,518 | |
Mar 05 2021 | SRPT | Sarepta Therapeuti ... | GRAY MARY ANN | Director | Grant | A | 0.00 | 2,726 | 0 | 8,436 | 5.7 K to 8.4 K (+47.74 %) |
Dec 21 2020 | KROS | Keros Therapeutics ... | GRAY MARY ANN | Director | Option Exercise | A | 82.74 | 16,587 | 1,372,408 | 16,587 | |
Dec 10 2020 | SRPT | Sarepta Therapeuti ... | GRAY MARY ANN | Director | Option Exercise | M | 0.00 | 967 | 0 | 967 | |
Dec 10 2020 | SRPT | Sarepta Therapeuti ... | GRAY MARY ANN | Director | Buy | M | 0.00 | 967 | 0 | 5,710 | 4.7 K to 5.7 K (+20.39 %) |
Jun 19 2020 | RAPT | RAPT Therapeutics, ... | GRAY MARY ANN | Director | Option Exercise | A | 28.27 | 7,500 | 212,025 | 7,500 | |
Apr 07 2020 | SNCA | Seneca Biopharma, ... | GRAY MARY ANN | Director | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
Apr 02 2020 | RAPT | RAPT Therapeutics, ... | GRAY MARY ANN | Director | Option Exercise | A | 21.27 | 3,984 | 84,740 | 3,984 | |
Feb 28 2020 | SRPT | Sarepta Therapeuti ... | GRAY MARY ANN | Director | Option Exercise | A | 114.47 | 3,685 | 421,822 | 3,685 | |
Feb 28 2020 | SRPT | Sarepta Therapeuti ... | GRAY MARY ANN | Director | Grant | A | 0.00 | 2,075 | 0 | 4,743 | 2.7 K to 4.7 K (+77.77 %) |
Dec 10 2019 | SRPT | Sarepta Therapeuti ... | GRAY MARY ANN | Director | Option Exercise | M | 0.00 | 967 | 0 | 1,934 | |
Dec 10 2019 | SRPT | Sarepta Therapeuti ... | GRAY MARY ANN | Director | Buy | M | 0.00 | 967 | 0 | 2,668 | 1.7 K to 2.7 K (+56.85 %) |
Dec 06 2019 | RAPT | RAPT Therapeutics, ... | GRAY MARY ANN | Director | Option Exercise | A | 27.53 | 22,500 | 619,425 | 22,500 | |
Mar 04 2019 | SRPT | Sarepta Therapeuti ... | GRAY MARY ANN | Director | Option Exercise | A | 145.48 | 3,213 | 467,427 | 3,213 | |
Mar 04 2019 | SRPT | Sarepta Therapeuti ... | GRAY MARY ANN | Director | Grant | A | 0.00 | 1,633 | 0 | 1,701 | 68 to 1.7 K (+2,401.47 %) |
Dec 11 2018 | SRPT | Sarepta Therapeuti ... | GRAY MARY ANN | Director | Option Exercise | A | 0.00 | 2,901 | 0 | 2,901 | |
Dec 11 2018 | SRPT | Sarepta Therapeuti ... | GRAY MARY ANN | Director | Option Exercise | A | 122.80 | 5,711 | 701,311 | 5,711 | |
Nov 02 2018 | SNMX | SENOMYX INC | GRAY MARY ANN | Director | Option Exercise | D | 1.36 | 20,000 | 27,200 | 0 | |
Nov 02 2018 | SNMX | SENOMYX INC | GRAY MARY ANN | Director | Option Exercise | D | 0.90 | 20,000 | 17,970 | 0 | |
Nov 02 2018 | SNMX | SENOMYX INC | GRAY MARY ANN | Director | Sell | U | 1.50 | 10,000 | 15,000 | 0 | 10 K to 0 (-100.00 %) |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | GRAY MARY ANN | Director | Sell | D | 11.50 | 16,244 | 186,806 | 0 | 16.2 K to 0 (-100.00 %) |
May 25 2018 | SNMX | SENOMYX INC | GRAY MARY ANN | Director | Option Exercise | A | 1.36 | 20,000 | 27,200 | 20,000 | |
Oct 10 2017 | GALE | Galena Biopharma, ... | GRAY MARY ANN | Director | Grant | A | 0.38 | 15,472 | 5,879 | 39,167 | 23.7 K to 39.2 K (+65.30 %) |
Jul 06 2017 | GALE | Galena Biopharma, ... | GRAY MARY ANN | Director | Option Exercise | A | 0.55 | 5,000 | 2,750 | 5,000 | |
Jul 06 2017 | GALE | Galena Biopharma, ... | GRAY MARY ANN | Director | Grant | A | 0.59 | 9,866 | 5,821 | 23,695 | 13.8 K to 23.7 K (+71.34 %) |
May 22 2017 | SNMX | SENOMYX INC | GRAY MARY ANN | Director | Option Exercise | A | 0.90 | 20,000 | 17,970 | 20,000 | |
Apr 12 2017 | GALE | Galena Biopharma, ... | GRAY MARY ANN | Director | Grant | A | 0.59 | 8,815 | 5,201 | 13,829 | 5 K to 13.8 K (+175.81 %) |
Mar 27 2017 | SNMX | SENOMYX INC | GRAY MARY ANN | Director | Buy | P | 1.00 | 10,000 | 10,000 | 10,000 | 0 to 10 K |
Jan 24 2017 | GALE | Galena Biopharma, ... | GRAY MARY ANN | Director | Grant | A | 1.98 | 2,525 | 5,000 | 5,004 | 2.5 K to 5 K (+101.86 %) |
Aug 03 2016 | JNP | JUNIPER PHARMACEUT ... | GRAY MARY ANN | Director | Grant | A | 0.00 | 6,064 | 0 | 7,334 | 1.3 K to 7.3 K (+477.48 %) |
Jul 18 2016 | GALE | Galena Biopharma, ... | GRAY MARY ANN | Director | Option Exercise | A | 0.41 | 100,000 | 41,000 | 100,000 | |
Jun 09 2016 | ACAD | ACADIA PHARMACEUTI ... | GRAY MARY ANN | Option Exercise | M | 9.04 | 10,000 | 90,400 | 0 | ||
Jun 09 2016 | ACAD | ACADIA PHARMACEUTI ... | GRAY MARY ANN | Option Exercise | M | 9.04 | 6,637 | 59,998 | 0 | ||
Jun 09 2016 | ACAD | ACADIA PHARMACEUTI ... | GRAY MARY ANN | Buy | M | 9.04 | 10,000 | 90,400 | 149,476 | 139.5 K to 149.5 K (+7.17 %) | |
Jun 09 2016 | ACAD | ACADIA PHARMACEUTI ... | GRAY MARY ANN | Buy | M | 9.04 | 6,637 | 59,998 | 139,476 | 132.8 K to 139.5 K (+5.00 %) | |
May 24 2016 | SNMX | SENOMYX INC | GRAY MARY ANN | Director | Option Exercise | A | 2.13 | 20,000 | 42,600 | 20,000 | |
Apr 06 2016 | JNP | JUNIPER PHARMACEUT ... | GRAY MARY ANN | Director | Grant | A | 0.00 | 1,270 | 0 | 1,270 | 0 to 1.3 K |
Apr 07 2016 | ACAD | ACADIA PHARMACEUTI ... | GRAY MARY ANN | Option Exercise | M | 1.36 | 10,000 | 13,600 | 0 | ||
Apr 07 2016 | ACAD | ACADIA PHARMACEUTI ... | GRAY MARY ANN | Option Exercise | M | 1.36 | 55,147 | 75,000 | 0 | ||
Apr 07 2016 | ACAD | ACADIA PHARMACEUTI ... | GRAY MARY ANN | Option Exercise | M | 1.30 | 57,692 | 75,000 | 0 | ||
Apr 07 2016 | ACAD | ACADIA PHARMACEUTI ... | GRAY MARY ANN | Option Exercise | M | 1.30 | 10,000 | 13,000 | 0 | ||
Apr 07 2016 | ACAD | ACADIA PHARMACEUTI ... | GRAY MARY ANN | Buy | M | 1.36 | 10,000 | 13,600 | 132,839 | 122.8 K to 132.8 K (+8.14 %) | |
Apr 07 2016 | ACAD | ACADIA PHARMACEUTI ... | GRAY MARY ANN | Buy | M | 1.36 | 55,147 | 75,000 | 122,839 | 67.7 K to 122.8 K (+81.47 %) | |
Apr 07 2016 | ACAD | ACADIA PHARMACEUTI ... | GRAY MARY ANN | Buy | M | 1.30 | 57,692 | 75,000 | 67,692 | 10 K to 67.7 K (+576.92 %) | |
Apr 07 2016 | ACAD | ACADIA PHARMACEUTI ... | GRAY MARY ANN | Buy | M | 1.30 | 10,000 | 13,000 | 10,000 | 0 to 10 K | |
Apr 28 2016 | GALE | Galena Biopharma, ... | GRAY MARY ANN | Director | Option Exercise | A | 1.40 | 200,000 | 280,000 | 200,000 | |
Jan 22 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Option Exercise | D | 26.23 | 16,667 | 437,175 | 0 | ||
Jan 22 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Sell | D | 0.00 | 232,440 | 0 | 0 | 232.4 K to 0 (-100.00 %) | |
Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Option Exercise | M | 26.23 | 33,333 | 874,325 | 16,667 | |
Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Option Exercise | M | 6.17 | 25,000 | 154,250 | 0 | |
Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Option Exercise | M | 2.06 | 8,107 | 16,700 | 0 | |
Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Option Exercise | M | 2.09 | 75,000 | 156,750 | 0 | |
Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Option Exercise | M | 3.82 | 75,000 | 286,500 | 0 | |
Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Option Exercise | M | 2.97 | 6,000 | 17,820 | 0 | |
Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Buy | M | 26.23 | 33,333 | 874,325 | 232,440 | 199.1 K to 232.4 K (+16.74 %) |
Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Buy | M | 6.17 | 25,000 | 154,250 | 199,107 | 174.1 K to 199.1 K (+14.36 %) |
Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Buy | M | 2.06 | 8,107 | 16,700 | 174,107 | 166 K to 174.1 K (+4.88 %) |
Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Buy | M | 2.09 | 75,000 | 156,750 | 166,000 | 91 K to 166 K (+82.42 %) |
Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Buy | M | 3.82 | 75,000 | 286,500 | 91,000 | 16 K to 91 K (+468.75 %) |
Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Buy | M | 2.97 | 6,000 | 17,820 | 16,000 | 10 K to 16 K (+60.00 %) |
Jun 17 2015 | ACAD | ACADIA PHARMACEUTI ... | GRAY MARY ANN | Option Exercise | A | 39.06 | 12,500 | 488,250 | 12,500 | ||
May 22 2015 | SNMX | SENOMYX INC | GRAY MARY ANN | Director | Option Exercise | A | 5.47 | 20,000 | 109,400 | 20,000 | |
May 14 2015 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Option Exercise | A | 26.23 | 50,000 | 1,311,500 | 50,000 | |
May 31 2005 | MBVX | MABVAX THERAPEUTIC ... | GRAY MARY ANN | Director | Option Exercise | A | 14.56 | 5,000 | 72,800 | 5,000 | |
Mar 17 2005 | MBVX | MABVAX THERAPEUTIC ... | GRAY MARY ANN | Director | Buy | P | 15.70 | 1,750 | 27,475 | 5,000 | 3.3 K to 5 K (+53.85 %) |
Mar 17 2005 | MBVX | MABVAX THERAPEUTIC ... | GRAY MARY ANN | Director | Buy | P | 15.48 | 500 | 7,740 | 3,250 | 2.8 K to 3.3 K (+18.18 %) |
Mar 17 2005 | MBVX | MABVAX THERAPEUTIC ... | GRAY MARY ANN | Director | Buy | P | 15.47 | 2,650 | 40,996 | 2,750 | 100 to 2.8 K (+2,650.00 %) |
Mar 17 2005 | MBVX | MABVAX THERAPEUTIC ... | GRAY MARY ANN | Director | Buy | P | 15.69 | 100 | 1,569 | 100 | 0 to 100 |
May 14 2004 | MBVX | MABVAX THERAPEUTIC ... | GRAY MARY ANN | Director | Option Exercise | A | 23.25 | 5,000 | 116,250 | 5,000 |
Page: 1